» Articles » PMID: 39702404

Clinical Significance and Biological Roles of LncRNA CTBP1-AS in Polycystic Ovary Syndrome

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic ovary syndrome (PCOS) is among the most prevalent endocrine and metabolic disorders affecting women of reproductive age. Multiple factors, including genetic predisposition, environmental influences, and lifestyle choices, are considered significant contributors to the development of PCOS. A kind of long noncoding RNA-C-Terminal binding protein 1 antisense (lncRNA CTBP1-AS) has been proven to be a new androgen receptor regulator. Previous studies showed that the lncRNA CTBP1-AS gene was highly expressed in a small sample of PCOS patients and was associated with the risk of PCOS, but its specific function and mechanism have not been clearly reported. In this study, the expression of lncRNA CTBP1-AS was detected by real-time quantitative PCR (RT-qPCR) in PCOS patients. In addition, lncRNA CTBP1-AS was overexpressed in KGN cells to explore its effect on granulocyte function. The results showed that the expression levels of lncRNA CTBP1-AS were increased in peripheral blood mononuclear cells and follicular fluid granulosa cells of PCOS patients compared with controls, which correlated with androgen levels and sinus follicle number; overexpression of lncRNA CTBP1-AS increased apoptosis and decreased cell migration ability, thus promoting the progression of PCOS. This study explores new biomarkers and therapeutic targets for the clinical individualized diagnosis and treatment of PCOS.

References
1.
Sadeghi H, Adeli I, Calina D, Docea A, Mousavi T, Daniali M . Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int J Mol Sci. 2022; 23(2). PMC: 8775814. DOI: 10.3390/ijms23020583. View

2.
Liao B, Qi X, Yun C, Qiao J, Pang Y . Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development. Front Endocrinol (Lausanne). 2022; 13:815968. PMC: 8883052. DOI: 10.3389/fendo.2022.815968. View

3.
Szukiewicz D, Trojanowski S, Kociszewska A, Szewczyk G . Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)-Searching for Epigenetic Factors. Int J Mol Sci. 2022; 23(23). PMC: 9736994. DOI: 10.3390/ijms232314663. View

4.
Gao Y, Zou Y, Wu G, Zheng L . Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome. Front Med (Lausanne). 2023; 10:1193749. PMC: 10336225. DOI: 10.3389/fmed.2023.1193749. View

5.
Jin L, Yang Q, Zhou C, Liu L, Wang H, Hou M . Profiles for long non-coding RNAs in ovarian granulosa cells from women with PCOS with or without hyperandrogenism. Reprod Biomed Online. 2018; 37(5):613-623. DOI: 10.1016/j.rbmo.2018.08.005. View